|Articles|January 18, 2022
Process Impurities Clearance in Biologics
Author(s)Element
This white paper discusses developing optimal platform analytical methods with partner CDMOs for effective process impurities clearance in biological drug substances.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities
2
US Government Shutdown: Treating Regulatory Lapses as Predictable Operational Risks
3
Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases
4
Cellares Secures $257M to Scale Global Cell Therapy Manufacturing
5